Arterial stiffness and cardiovascular events: the Framingham Heart Study
- PMID: 20083680
- PMCID: PMC2836717
- DOI: 10.1161/CIRCULATIONAHA.109.886655
Arterial stiffness and cardiovascular events: the Framingham Heart Study
Abstract
Background: Various measures of arterial stiffness and wave reflection have been proposed as cardiovascular risk markers. Prior studies have not assessed relations of a comprehensive panel of stiffness measures to prognosis in the community.
Methods and results: We used proportional hazards models to analyze first-onset major cardiovascular disease events (myocardial infarction, unstable angina, heart failure, or stroke) in relation to arterial stiffness (pulse wave velocity [PWV]), wave reflection (augmentation index, carotid-brachial pressure amplification), and central pulse pressure in 2232 participants (mean age, 63 years; 58% women) in the Framingham Heart Study. During median follow-up of 7.8 (range, 0.2 to 8.9) years, 151 of 2232 participants (6.8%) experienced an event. In multivariable models adjusted for age, sex, systolic blood pressure, use of antihypertensive therapy, total and high-density lipoprotein cholesterol concentrations, smoking, and presence of diabetes mellitus, higher aortic PWV was associated with a 48% increase in cardiovascular disease risk (95% confidence interval, 1.16 to 1.91 per SD; P=0.002). After PWV was added to a standard risk factor model, integrated discrimination improvement was 0.7% (95% confidence interval, 0.05% to 1.3%; P<0.05). In contrast, augmentation index, central pulse pressure, and pulse pressure amplification were not related to cardiovascular disease outcomes in multivariable models.
Conclusions: Higher aortic stiffness assessed by PWV is associated with increased risk for a first cardiovascular event. Aortic PWV improves risk prediction when added to standard risk factors and may represent a valuable biomarker of cardiovascular disease risk in the community.
Figures
Comment in
-
Letter by O'Rourke et al regarding article, "Arterial stiffness and cardiovascular events: the Framingham Heart Study".Circulation. 2010 Nov 9;122(19):e512; author reply e515. doi: 10.1161/CIRCULATIONAHA.110.945089. Circulation. 2010. PMID: 21060081 No abstract available.
-
Letter by Weber et al regarding article, "Arterial stiffness and cardiovascular events: the Framingham Heart Study".Circulation. 2010 Nov 9;122(19):e513; author reply e515. doi: 10.1161/CIRCULATIONAHA.110.949073. Circulation. 2010. PMID: 21060082 No abstract available.
-
Letter by Safar and Jankowski regarding article, "Arterial stiffness and cardiovascular events: the Framingham Heart Study".Circulation. 2010 Nov 9;122(19):e514; author reply e515. doi: 10.1161/CIRCULATIONAHA.110.949487. Circulation. 2010. PMID: 21060083 No abstract available.
References
-
- Domanski MJ, Davis BR, Pfeffer MA, Kastantin M, Mitchell GF. Isolated systolic hypertension: prognostic information provided by pulse pressure. Hypertension. 1999;34:375–380. - PubMed
-
- Franklin SS, Khan SA, Wong ND, Larson MG, Levy D. Is pulse pressure useful in predicting risk for coronary heart Disease? The Framingham heart study. Circulation. 1999;100:354–360. - PubMed
-
- Mitchell GF, Moye LA, Braunwald E, Rouleau JL, Bernstein V, Geltman EM, Flaker GC, Pfeffer MA. Sphygmomanometrically determined pulse pressure is a powerful independent predictor of recurrent events after myocardial infarction in patients with impaired left ventricular function. SAVE investigators. Survival and Ventricular Enlargement. Circulation. 1997;96:4254–4260. - PubMed
-
- Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D, Pannier B, Vlachopoulos C, Wilkinson I, Struijker-Boudier H. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J. 2006;27:2588–2605. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 HL071039/HL/NHLBI NIH HHS/United States
- 2-K24-HL04334/HL/NHLBI NIH HHS/United States
- N01 HC025195/HC/NHLBI NIH HHS/United States
- R01 HL076784/HL/NHLBI NIH HHS/United States
- R01 HL060040/HL/NHLBI NIH HHS/United States
- HL080124/HL/NHLBI NIH HHS/United States
- N01 HC025195/HL/NHLBI NIH HHS/United States
- HL076784/HL/NHLBI NIH HHS/United States
- R01 HL080124/HL/NHLBI NIH HHS/United States
- R01 AG028321/AG/NIA NIH HHS/United States
- R01 HL070100/HL/NHLBI NIH HHS/United States
- HL071039/HL/NHLBI NIH HHS/United States
- N01-HC-25195/HC/NHLBI NIH HHS/United States
- HL070100/HL/NHLBI NIH HHS/United States
- AG028321/AG/NIA NIH HHS/United States
- HL077447/HL/NHLBI NIH HHS/United States
- K24 HL004334/HL/NHLBI NIH HHS/United States
- R01 HL077447/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical